Douglass Winthrop Advisors LLC increased its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 0.2% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 11,519 shares of the semiconductor company’s stock after purchasing an additional 25 shares during the period. Douglass Winthrop Advisors LLC’s holdings in Synopsys were worth $4,940,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. Brighton Jones LLC raised its holdings in Synopsys by 5.7% in the 4th quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock valued at $447,000 after acquiring an additional 50 shares in the last quarter. XTX Topco Ltd acquired a new stake in Synopsys in the 4th quarter valued at $228,000. Jump Financial LLC bought a new stake in Synopsys in the fourth quarter valued at $453,000. NewEdge Advisors LLC raised its stake in Synopsys by 5.1% during the fourth quarter. NewEdge Advisors LLC now owns 2,615 shares of the semiconductor company’s stock worth $1,269,000 after acquiring an additional 127 shares in the last quarter. Finally, Coppell Advisory Solutions LLC lifted its holdings in shares of Synopsys by 153.4% during the fourth quarter. Coppell Advisory Solutions LLC now owns 446 shares of the semiconductor company’s stock valued at $217,000 after acquiring an additional 270 shares during the period. Institutional investors and hedge funds own 85.47% of the company’s stock.
Synopsys Stock Performance
SNPS stock opened at $606.52 on Friday. The company has a 50 day moving average price of $570.29 and a 200 day moving average price of $500.95. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $651.73. The company has a debt-to-equity ratio of 1.01, a current ratio of 7.02 and a quick ratio of 6.85. The stock has a market capitalization of $94.11 billion, a PE ratio of 43.79, a price-to-earnings-growth ratio of 3.93 and a beta of 1.15.
Insiders Place Their Bets
In other Synopsys news, CFO Shelagh Glaser sold 7,310 shares of the firm’s stock in a transaction that occurred on Friday, June 6th. The shares were sold at an average price of $485.72, for a total transaction of $3,550,613.20. Following the sale, the chief financial officer directly owned 15,291 shares in the company, valued at approximately $7,427,144.52. This trade represents a 32.34% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Sassine Ghazi sold 11,366 shares of the firm’s stock in a transaction on Monday, June 2nd. The stock was sold at an average price of $457.93, for a total transaction of $5,204,832.38. Following the sale, the chief executive officer owned 71,589 shares in the company, valued at approximately $32,782,750.77. The trade was a 13.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 27,686 shares of company stock worth $13,001,048. Company insiders own 0.62% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities analysts recently issued reports on the stock. Stifel Nicolaus set a $550.00 price target on shares of Synopsys in a report on Monday, April 28th. Rosenblatt Securities lifted their target price on shares of Synopsys from $625.00 to $650.00 and gave the company a “buy” rating in a research note on Friday, July 25th. Needham & Company LLC reissued a “buy” rating and issued a $660.00 target price (up from $650.00) on shares of Synopsys in a report on Tuesday, July 15th. The Goldman Sachs Group initiated coverage on Synopsys in a report on Thursday, July 10th. They set a “buy” rating and a $620.00 price target for the company. Finally, Piper Sandler boosted their price objective on Synopsys from $615.00 to $660.00 and gave the stock an “overweight” rating in a research note on Monday, July 21st. Twelve investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Synopsys presently has a consensus rating of “Moderate Buy” and a consensus price target of $626.79.
Get Our Latest Stock Report on Synopsys
Synopsys Company Profile
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- The Most Important Warren Buffett Stock for Investors: His Own
- MarketBeat Week in Review – 08/18 – 08/22
- What is the Dow Jones Industrial Average (DJIA)?
- Royal Caribbean Earnings Beat Fuels Strong 2025 Outlook
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Alphabet’s Breakout Potential: From Laggard to AI Leader
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.